Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits

Luca Brunelli, Eric Hamilton, Jonathan M. Davis, Hshi Chi Koo, Ansamma Joseph, Jeffrey A. Kazzaz, Marla R. Wolfson, Thomas H. Shaffer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Previous studies suggest acute lung injury (ALI) in premature newborns is associated with relative deficiency of antioxidant enzymes that may be ameliorated by recombinant human superoxide dismutase (rhSOD). Perfluorochemicals (PFCs) are distributed homogeneously and support gas exchange in diseased lungs. We investigated whether PFCs could provide an effective delivery system for rhSOD. Juvenile rabbits were lung-lavaged, treated with surfactant, and randomized: group I: fluorescently labeled rhSOD (5 mg/kg in 2 mL/kg saline); group II: fluorescently labeled rhSOD (5 mg/kg in 18 mL/kg PFC). Animals were ventilated with oxygen for 4 h; the lungs were harvested for analysis of SOD distribution and oxidative injury. Cardiopulmonary indices remained stable and similar between groups. Qualitative assessment (QA) showed a more homogeneous lung SOD distribution in group II and a better histologic profile. QA of lung SOD distribution showed significant increase in SOD concentrations in group II (7.37 ± 1.54 μg/mg protein) compared with group I (1.65 ± 0.23 μg/mg protein). Oxidative injury as assessed by normalized protein carbonyl was 149.1 ± 26.8% SEM in group II compared with 200.5 ± 7.3% SEM in group I. Plasma SOD was significantly higher in group II. Administration of rhSOD with or without PFCs does not compromise cardiovascular function or impede lung recovery after ALI. PFCs enhance rhSOD delivery to the lungs by 400% while decreasing lung oxidative damage by 25% compared with rhSOD alone. These data suggest that PFCs optimize lung rhSOD delivery and might enhance the beneficial effects of rhSOD in preventing acute and chronic lung injury.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalPediatric Research
Volume60
Issue number1
DOIs
StatePublished - Jul 1 2006

Fingerprint

Superoxide Dismutase
Rabbits
Lung
Acute Lung Injury
Proteins
Wounds and Injuries
Lung Injury
Surface-Active Agents
Lung Diseases
Antioxidants
Gases
Oxygen
Enzymes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits. / Brunelli, Luca; Hamilton, Eric; Davis, Jonathan M.; Koo, Hshi Chi; Joseph, Ansamma; Kazzaz, Jeffrey A.; Wolfson, Marla R.; Shaffer, Thomas H.

In: Pediatric Research, Vol. 60, No. 1, 01.07.2006, p. 65-70.

Research output: Contribution to journalArticle

Brunelli, L, Hamilton, E, Davis, JM, Koo, HC, Joseph, A, Kazzaz, JA, Wolfson, MR & Shaffer, TH 2006, 'Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits', Pediatric Research, vol. 60, no. 1, pp. 65-70. https://doi.org/10.1203/01.pdr.0000219392.73509.70
Brunelli, Luca ; Hamilton, Eric ; Davis, Jonathan M. ; Koo, Hshi Chi ; Joseph, Ansamma ; Kazzaz, Jeffrey A. ; Wolfson, Marla R. ; Shaffer, Thomas H. / Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits. In: Pediatric Research. 2006 ; Vol. 60, No. 1. pp. 65-70.
@article{d36270b76a58487992d84c95d06148bf,
title = "Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits",
abstract = "Previous studies suggest acute lung injury (ALI) in premature newborns is associated with relative deficiency of antioxidant enzymes that may be ameliorated by recombinant human superoxide dismutase (rhSOD). Perfluorochemicals (PFCs) are distributed homogeneously and support gas exchange in diseased lungs. We investigated whether PFCs could provide an effective delivery system for rhSOD. Juvenile rabbits were lung-lavaged, treated with surfactant, and randomized: group I: fluorescently labeled rhSOD (5 mg/kg in 2 mL/kg saline); group II: fluorescently labeled rhSOD (5 mg/kg in 18 mL/kg PFC). Animals were ventilated with oxygen for 4 h; the lungs were harvested for analysis of SOD distribution and oxidative injury. Cardiopulmonary indices remained stable and similar between groups. Qualitative assessment (QA) showed a more homogeneous lung SOD distribution in group II and a better histologic profile. QA of lung SOD distribution showed significant increase in SOD concentrations in group II (7.37 ± 1.54 μg/mg protein) compared with group I (1.65 ± 0.23 μg/mg protein). Oxidative injury as assessed by normalized protein carbonyl was 149.1 ± 26.8{\%} SEM in group II compared with 200.5 ± 7.3{\%} SEM in group I. Plasma SOD was significantly higher in group II. Administration of rhSOD with or without PFCs does not compromise cardiovascular function or impede lung recovery after ALI. PFCs enhance rhSOD delivery to the lungs by 400{\%} while decreasing lung oxidative damage by 25{\%} compared with rhSOD alone. These data suggest that PFCs optimize lung rhSOD delivery and might enhance the beneficial effects of rhSOD in preventing acute and chronic lung injury.",
author = "Luca Brunelli and Eric Hamilton and Davis, {Jonathan M.} and Koo, {Hshi Chi} and Ansamma Joseph and Kazzaz, {Jeffrey A.} and Wolfson, {Marla R.} and Shaffer, {Thomas H.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1203/01.pdr.0000219392.73509.70",
language = "English (US)",
volume = "60",
pages = "65--70",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits

AU - Brunelli, Luca

AU - Hamilton, Eric

AU - Davis, Jonathan M.

AU - Koo, Hshi Chi

AU - Joseph, Ansamma

AU - Kazzaz, Jeffrey A.

AU - Wolfson, Marla R.

AU - Shaffer, Thomas H.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Previous studies suggest acute lung injury (ALI) in premature newborns is associated with relative deficiency of antioxidant enzymes that may be ameliorated by recombinant human superoxide dismutase (rhSOD). Perfluorochemicals (PFCs) are distributed homogeneously and support gas exchange in diseased lungs. We investigated whether PFCs could provide an effective delivery system for rhSOD. Juvenile rabbits were lung-lavaged, treated with surfactant, and randomized: group I: fluorescently labeled rhSOD (5 mg/kg in 2 mL/kg saline); group II: fluorescently labeled rhSOD (5 mg/kg in 18 mL/kg PFC). Animals were ventilated with oxygen for 4 h; the lungs were harvested for analysis of SOD distribution and oxidative injury. Cardiopulmonary indices remained stable and similar between groups. Qualitative assessment (QA) showed a more homogeneous lung SOD distribution in group II and a better histologic profile. QA of lung SOD distribution showed significant increase in SOD concentrations in group II (7.37 ± 1.54 μg/mg protein) compared with group I (1.65 ± 0.23 μg/mg protein). Oxidative injury as assessed by normalized protein carbonyl was 149.1 ± 26.8% SEM in group II compared with 200.5 ± 7.3% SEM in group I. Plasma SOD was significantly higher in group II. Administration of rhSOD with or without PFCs does not compromise cardiovascular function or impede lung recovery after ALI. PFCs enhance rhSOD delivery to the lungs by 400% while decreasing lung oxidative damage by 25% compared with rhSOD alone. These data suggest that PFCs optimize lung rhSOD delivery and might enhance the beneficial effects of rhSOD in preventing acute and chronic lung injury.

AB - Previous studies suggest acute lung injury (ALI) in premature newborns is associated with relative deficiency of antioxidant enzymes that may be ameliorated by recombinant human superoxide dismutase (rhSOD). Perfluorochemicals (PFCs) are distributed homogeneously and support gas exchange in diseased lungs. We investigated whether PFCs could provide an effective delivery system for rhSOD. Juvenile rabbits were lung-lavaged, treated with surfactant, and randomized: group I: fluorescently labeled rhSOD (5 mg/kg in 2 mL/kg saline); group II: fluorescently labeled rhSOD (5 mg/kg in 18 mL/kg PFC). Animals were ventilated with oxygen for 4 h; the lungs were harvested for analysis of SOD distribution and oxidative injury. Cardiopulmonary indices remained stable and similar between groups. Qualitative assessment (QA) showed a more homogeneous lung SOD distribution in group II and a better histologic profile. QA of lung SOD distribution showed significant increase in SOD concentrations in group II (7.37 ± 1.54 μg/mg protein) compared with group I (1.65 ± 0.23 μg/mg protein). Oxidative injury as assessed by normalized protein carbonyl was 149.1 ± 26.8% SEM in group II compared with 200.5 ± 7.3% SEM in group I. Plasma SOD was significantly higher in group II. Administration of rhSOD with or without PFCs does not compromise cardiovascular function or impede lung recovery after ALI. PFCs enhance rhSOD delivery to the lungs by 400% while decreasing lung oxidative damage by 25% compared with rhSOD alone. These data suggest that PFCs optimize lung rhSOD delivery and might enhance the beneficial effects of rhSOD in preventing acute and chronic lung injury.

UR - http://www.scopus.com/inward/record.url?scp=33748084401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748084401&partnerID=8YFLogxK

U2 - 10.1203/01.pdr.0000219392.73509.70

DO - 10.1203/01.pdr.0000219392.73509.70

M3 - Article

VL - 60

SP - 65

EP - 70

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -